Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Dr Paisey talks to ecancer at the PETIC centre in Wales about the difficulties of working with novel, longer lasting radiotracers and radiometals created using the cyclotron located at the centre.
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Best practice in HRRm testing in patients with metastatic prostate cancer
Synthetic biology and precision medicine in blood and gynaecological cancers
Choosing Wisely in radiology Tanzania
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Why tumour markers are not recommended as screening tests
War in Ukraine: The logistical challenges of transferring medical materials
Advancing breast cancer diagnosis in the developing world
Moving to the future: Artificial intelligence in surgery